Home > Search: Ranitidine Bismuth Citrate

• Search Results

Search Results Get Your Free Credit Report Right Now! Zip Code: Join our discussion forums! Providers join our directory! General Topics A-Z Conditions Treatments Medications Fitness Nutrition Anatomy Travel/Destinations Other Topics From the West From the East

Main Topic Area Ranitidine Bismuth Citrate All Topic Areas 1 - 10 of 76  more >> Ranitidine Bismuth Citrate Tritec Ranitidine Zantac Zantac 75 Ranitidine Oral Syrup Zantac Syrup Ranitidine Hydrochloride Injection Zantac Injection Bismuth Subsalicylate News 1 - 5 of 14  more >> Actavis Receives Approval For Ranitidine Syrup In The U.S. MedicalNewsToday - Sat, 03 Mar 2007 08:00 EST FDA Approves First Medication To Treat And Prevent Vomiting In Dogs MedicalNewsToday - Thu, 01 Mar 2007 08:00 EST Nonarteritic Anterior Ischemic Optic Neuropathy In Men Using Sildenafil Citrate For Erectile Dysfunction: A Review Of >44,800 Patients In Clinical And MedicalNewsToday - Sat, 04 Nov 2006 08:00 EST Anti-acid supplement boosts bone mass Reuters - Fri, 20 Oct 2006 02:29 EST Base Supplements May Help Fight Osteoporosis MedicalNewsToday - Sun, 15 Oct 2006 07:00 EST Clinical Trials 1 - 5 of 61  more >> Open Label Extension Study Evaluating Sildenafil Citrate When Used In Combination with Epoprostenol In PAH ClinicalTrials.gov Identifier: NCT00147641 - Active, not recruiting Pulmonary Hypertension Long Term Extension Study Evaluating Safety of Sildenafil Citrate When Used to Treat PAH in Children ClinicalTrials.gov Identifier: NCT00159874 - Recruiting Pulmonary Hypertension Randomized Study of Sildenafil Citrate During & After Radiotherapy for Erectile Ftn Vs Radiotherapy for Prostate Ca ClinicalTrials.gov Identifier: NCT00142506 - Recruiting Prostate Cancer Safety & Efficacy of Toremifene Citrate for Prevention of Bone Fractures in Men with Prostate Cancer on Androgen Deprivation Therapy ClinicalTrials.gov Identifier: NCT00129142 - Active, not recruiting Prostate Cancer; Osteoporosis; Bone Loss; Fractures A Pilot Randomized, Double-Blind, Placebo-Controlled, Parallel Design, Multicenter Trial to Evaluate the Effect of Ranitidine on Immunologic Indicators in Asymptomatic HIV-1 Infected Subjects With a CD4 Cell Count Between 400-700 Cells/mm3 ClinicalTrials.gov Identifier: NCT00002106 - Completed HIV Infections

GoldBambooTM Your Integrative Health and Wellness Resource December 3, 2009

email this page   |    print this page   |    bookmark this page   |    feedback on this page Page Updated: January 17, 2009

Disclaimer: All material displayed on the GoldBamboo.com website is provided for educational purposes only. Consult a physician regarding the applicability of any information found on GoldBamboo.com to your symptoms or medical condition.